Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
China · Delayed Price · Currency is CNY 23.49
+0.28 (1.21%)
At close: Jun 12, 2026
SHA:688217 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -58.72 | -50.38 | -15.76 | 7.93 | 40.47 | 47.33 |
Depreciation & Amortization | 37.62 | 37.62 | 45.67 | 44.4 | 35.73 | 37.52 |
Other Amortization | 2.98 | 2.98 | 0.98 | 1.18 | 2.77 | 4.06 |
Loss (Gain) From Sale of Assets | -0.13 | -0.13 | -0.12 | -0.84 | 0.01 | 0.1 |
Asset Writedown & Restructuring Costs | 25.43 | 25.43 | 16.67 | 7.64 | 14.16 | -1.5 |
Loss (Gain) From Sale of Investments | -3.46 | -3.46 | -2.49 | -3.01 | -3.1 | -1.47 |
Provision & Write-off of Bad Debts | 14.01 | 14.01 | 6.65 | 5.03 | 9.56 | 1.06 |
Other Operating Activities | -5.14 | -4.66 | -8.6 | -10.87 | 21.64 | -5.28 |
Change in Accounts Receivable | 12.93 | 12.93 | 14.49 | 182.51 | -101.21 | 2.87 |
Change in Inventory | 6.98 | 6.98 | 9.79 | -15.93 | -16.97 | -10.8 |
Change in Accounts Payable | -0.78 | -0.78 | 2.86 | -167.29 | 64.84 | 3.62 |
Change in Other Net Operating Assets | -0.62 | -0.62 | -4.1 | 2.15 | 8.84 | - |
Operating Cash Flow | 36.73 | 45.55 | 59.98 | 45.1 | 73.07 | 77.97 |
Operating Cash Flow Growth | -37.74% | -24.06% | 33.00% | -38.28% | -6.28% | 11.20% |
Capital Expenditures | -25.46 | -26.76 | -39.41 | -109.09 | -106.57 | -95.6 |
Sale of Property, Plant & Equipment | 0.27 | 0.27 | 0.14 | 0.22 | - | 1.39 |
Investment in Securities | 13.54 | -22.62 | -21.98 | 3.56 | 109.03 | -188.56 |
Other Investing Activities | 2.46 | 2.37 | 1.99 | 2.74 | 4.58 | 4.19 |
Investing Cash Flow | -9.19 | -46.74 | -59.27 | -102.58 | 7.04 | -278.57 |
Long-Term Debt Issued | - | - | - | 20 | 1.35 | - |
Total Debt Issued | - | - | - | 20 | 1.35 | - |
Long-Term Debt Repaid | - | -19.43 | -6.06 | -7.22 | -5.87 | -4.62 |
Total Debt Repaid | -3.18 | -19.43 | -6.06 | -7.22 | -5.87 | -4.62 |
Net Debt Issued (Repaid) | -3.18 | -19.43 | -6.06 | 12.78 | -4.52 | -4.62 |
Issuance of Common Stock | - | - | - | 8.97 | - | 224.04 |
Repurchase of Common Stock | - | - | -17.03 | - | - | - |
Common Dividends Paid | -9.4 | -9.5 | -0.62 | -10.4 | -0.01 | -0.02 |
Other Financing Activities | 0.24 | - | - | - | - | -27.59 |
Financing Cash Flow | -12.35 | -28.94 | -23.7 | 11.36 | -4.53 | 191.8 |
Foreign Exchange Rate Adjustments | -1.06 | -1.01 | 0.66 | 0.84 | 4.69 | -1.54 |
Net Cash Flow | 14.13 | -31.14 | -22.33 | -45.29 | 80.26 | -10.35 |
Free Cash Flow | 11.27 | 18.79 | 20.57 | -64 | -33.5 | -17.63 |
Free Cash Flow Growth | -47.31% | -8.67% | - | - | - | - |
Free Cash Flow Margin | 6.92% | 10.60% | 8.49% | -24.79% | -7.90% | -6.06% |
Free Cash Flow Per Share | 0.20 | 0.34 | 0.36 | -1.13 | -0.60 | -0.35 |
Cash Income Tax Paid | 20.53 | 19.94 | 9.99 | 17.59 | 1.16 | -1.81 |
Levered Free Cash Flow | 16.67 | 20.61 | 25.84 | -63.29 | -58.2 | -31.58 |
Unlevered Free Cash Flow | 16.9 | 20.73 | 26.39 | -62.77 | -57.86 | -31.28 |
Change in Working Capital | 24.12 | 24.12 | 16.98 | -6.36 | -48.18 | -3.86 |